NCT00930436 - Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease | Biotech Hunter

Enrollment

391

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions

Contrast Induced Kidney Injury.

Interventions

DRUG

sodium bicarbonate

Serum creatinine will be measured on Days 3,7, 30, 90, and 180

Trial Locations (17)

10029

Mt Sinai School of Medcine, New York

17822

Geisinger Medical Center, Danville

18015

St Luke's Heart and Vascular Center, Bethlehem

30165

Redmond Regional Medical Center, Rome

33709

Northside Hospital, St. Petersburg

34741

Osceola Regional Medical Center, Kissimmee

37203

Centennial Medical Center, Nashville

62701

St. Johns Hospital, Springfield

64111

St Luke's Health System, Kansas City

75227

Baylor Heart and Vascular Hospital, Dallas

Unknown

Beth Israel Deaconess Medical Center, Boston

Stony Brook University Medical Center, Stony Brook

The Christ Hospital, Cincinnati

07601

Hackensack University Medical Center, Hackensack

02903

Rhode Island Hospital, Providence

02906

The Miriam Hospital (Lifespan), Providence

05401

Fletcher Allen Hospital, Burlington